Dataset from Multicenter, Double-Blind, Parallel, Placebo-Controlled, Randomised Phase 3 Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis: 12-Week Final Data
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006769
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study was to compare the efficacy of etanercept (25 mg, twice
weekly) with that of placebo based on the percentage of patients who achieve the Assessment
in Ankylosing Spondylitis (ASAS) response criteria (ASAS 20%) at week 12.
创建时间：
2025-12-03
